http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113030472-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57419 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate | 2021-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-113030472-B |
| titleOfInvention | Application of mitochondrial protein SUCLG2 in the diagnosis and prognosis of colorectal cancer |
| abstract | The invention discloses the application of the mitochondrial protein SUCLG2 in the diagnosis and prognosis judgment of colorectal cancer. The first aspect of the present application provides the application of a reagent for quantitative detection of SUCLG2 in the preparation of products for the diagnosis and/or prognosis of colorectal cancer. According to the application of the embodiment of the present application, it has at least the following beneficial effects: the applicant unexpectedly found that the mitochondrial protein and its mRNA are significantly differentially expressed between colorectal cancer patients and normal people, so it can The detection of SUCLG2 at the nucleic acid and/or protein level can be used to effectively diagnose or judge whether there is colorectal cancer and the prognosis of colorectal cancer. |
| priorityDate | 2021-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 23.